Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 2
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Exploring new pathways in endocrine-resistant breast cancer.
de Pinho IS, Abreu C, Gomes I, Casimiro S, Pacheco TR, de Sousa RT, Costa L. de Pinho IS, et al. Among authors: de sousa rt. Explor Target Antitumor Ther. 2022;3(3):337-361. doi: 10.37349/etat.2022.00086. Epub 2022 Jun 20. Explor Target Antitumor Ther. 2022. PMID: 36045911 Free PMC article. Review.
Breast Sarcomas, Phyllodes Tumors, and Desmoid Tumors: Turning the Magnifying Glass on Rare and Aggressive Entities.
Esperança-Martins M, Melo-Alvim C, Dâmaso S, Lopes-Brás R, Peniche T, Nogueira-Costa G, Abreu C, Luna Pais H, de Sousa RT, Torres S, Gallego-Paez LM, Martins M, Ribeiro L, Costa L. Esperança-Martins M, et al. Among authors: de sousa rt. Cancers (Basel). 2023 Aug 2;15(15):3933. doi: 10.3390/cancers15153933. Cancers (Basel). 2023. PMID: 37568749 Free PMC article. Review.
BRAF L597K mutation: an opportunity to treat.
Lobo-Martins S, Pais HL, Soares-de-Almeida L, Costa L, Mansinho A, Teixeira de Sousa R. Lobo-Martins S, et al. Among authors: teixeira de sousa r. Dermatol Online J. 2021 Jan 15;27(1):13030/qt18k3573s. Dermatol Online J. 2021. PMID: 33560788 Free article.
Immunotherapy around the Clock: Impact of Infusion Timing on Stage IV Melanoma Outcomes.
Gonçalves L, Gonçalves D, Esteban-Casanelles T, Barroso T, Soares de Pinho I, Lopes-Brás R, Esperança-Martins M, Patel V, Torres S, Teixeira de Sousa R, Mansinho A, Costa L. Gonçalves L, et al. Among authors: teixeira de sousa r. Cells. 2023 Aug 15;12(16):2068. doi: 10.3390/cells12162068. Cells. 2023. PMID: 37626878 Free PMC article.
Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases: Final Results From the Phase 3 ATTAIN Randomized Clinical Trial.
Tripathy D, Tolaney SM, Seidman AD, Anders CK, Ibrahim N, Rugo HS, Twelves C, Diéras V, Müller V, Du Y, Currie SL, Hoch U, Tagliaferri M, Hannah AL, Cortés J; ATTAIN Investigators. Tripathy D, et al. JAMA Oncol. 2022 Jul 1;8(7):1047-1052. doi: 10.1001/jamaoncol.2022.0514. JAMA Oncol. 2022. PMID: 35552364 Free PMC article. Clinical Trial.
Anthracyclines versus No Anthracyclines in the Neoadjuvant Strategy for HER2+ Breast Cancer: Real-World Evidence.
de Pinho IS, Luz P, Alves L, Lopes-Brás R, Patel V, Esperança-Martins M, Gonçalves L, Freitas R, Simão D, Galnares MR, Fernandes I, Criado SA, Casado SG, Cañada JB, Vega IMS, Costa JG, Fernandes AS, de Sousa RT, Costa L. de Pinho IS, et al. Among authors: de sousa rt. Clin Drug Investig. 2023 Sep;43(9):691-698. doi: 10.1007/s40261-023-01291-6. Epub 2023 Jul 21. Clin Drug Investig. 2023. PMID: 37479867 Free PMC article.